期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 62, 期 18, 页码 8392-8411出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.9b00188
关键词
-
资金
- German Research Foundation [DFG-KF0325, DFG-LA2829/9-1, DFG-DI827/S-1, DFG-DI827/6-1]
- German Cancer Aid
- University Hospital Giessen -Marburg (UKGM)
Important steps in embryonic development are governed by the Hedgehog (Hh) signaling pathway, an evolutionary conserved signal transduction cascade. However, Hh activity not only is crucial during embryo formation but also is involved in adult tissue repair and in several malignancies. Particularly due to its link to cancer, small molecule Hh pathway inhibitors have been developed and the first compounds have been approved for use in Hh-driven basal cell carcinoma. Almost all advanced Hh inhibitors target the critical signaling component Smoothened (SMO), but preclinical research has identified additional compounds that can block the Hh pathway along its entire signaling cascade, which, in light of emerging drug resistance occurring with SMO inhibitors, is of high importance. Herein we give an overview on currently known Hh pathway inhibitors, delineating their respective strengths and weaknesses and describing potential drug targeting strategies to interfere with Hh signaling in different cancer settings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据